Veracyte, Inc. (VCYT)

Sector: Healthcare
Industry: Services-Medical Laboratories
Country: United States
Exchange: NASDAQ
Market cap: $3.20B

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

Latest financial period: June 30, 2026
Filed with the SEC: July 31, 2026
Estimated earnings date: November 3, 2026

Menu

Home

Compare

Next Earnings Reports

How this site works

Terms of use

About